Sign in to edit your profile (add interests, mentoring, photo, etc.)

    James Lightwood, PhD, MA

    TitleAssociate Professor
    SchoolUCSF School of Pharmacy
    DepartmentClinical Pharmacy
    Address3333 Calif. St,Laurel Heights
    San Francisco CA 94143
    Phone415-514-0939

       ORNG Applications 
       Websites
       In The News
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Mekonnen TA, Odden MC, Coxson PG, Guzman D, Lightwood J, Wang YC, Bibbins-Domingo K. Health Benefits of Reducing Sugar-Sweetened Beverage Intake in High Risk Populations of California: Results from the Cardiovascular Disease (CVD) Policy Model. PLoS One. 2013; 8(12):e81723.
        View in: PubMed
      2. Stebbins MR, Frear ME, Cutler TW, Lightwood JM, Fingado AR, Lai CJ, Lipton HL. Pharmacy students teaching prescribers strategies to lower prescription drug costs for underserved patients. J Manag Care Pharm. 2013 Sep; 19(7):534-41.
        View in: PubMed
      3. Lightwood J, Glantz SA. The effect of the California tobacco control program on smoking prevalence, cigarette consumption, and healthcare costs: 1989-2008. PLoS One. 2013; 8(2):e47145.
        View in: PubMed
      4. Max W, Sung HY, Lightwood J. The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016. Tob Control. 2013 May; 22(e1):e10-5.
        View in: PubMed
      5. Cheng KW, Glantz SA, Lightwood JM. Association between smokefree laws and voluntary smokefree-home rules. Am J Prev Med. 2011 Dec; 41(6):566-72.
        View in: PubMed
      6. Kim YA, Loucks A, Yokoyama G, Lightwood J, Rascate K, Serxner SA. Evaluation of value-based insurance design with a large retail employer. Am J Manag Care. 2011 Oct; 17(10):682-90.
        View in: PubMed
      7. Odden MC, Coxson PG, Moran A, Lightwood JM, Goldman L, Bibbins-Domingo K. The impact of the aging population on coronary heart disease in the United States. Am J Med. 2011 Sep; 124(9):827-33.e5.
        View in: PubMed
      8. Lightwood J, Glantz S. Effect of the Arizona tobacco control program on cigarette consumption and healthcare expenditures. Soc Sci Med. 2011 Jan; 72(2):166-72.
        View in: PubMed
      9. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18; 362(7):590-9.
        View in: PubMed
      10. Wang LM, Wong M, Lightwood JM, Cheng CM. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs. Ann Pharmacother. 2010 Jan; 44(1):28-34.
        View in: PubMed
      11. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health. 2009 Dec; 99(12):2230-7.
        View in: PubMed
      12. Lightwood JM, Glantz SA. Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation. 2009 Oct 6; 120(14):1373-9.
        View in: PubMed
      13. Pletcher MJ, Lazar L, Bibbins-Domingo K, Moran A, Rodondi N, Coxson P, Lightwood J, Williams L, Goldman L. Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering. Ann Intern Med. 2009 Feb 17; 150(4):243-54.
        View in: PubMed
      14. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L. Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med. 2009 Jan; 36(1):13-20.
        View in: PubMed
      15. Lightwood JM, Dinno A, Glantz SA. Effect of the California tobacco control program on personal health care expenditures. PLoS Med. 2008 Aug 26; 5(8):e178.
        View in: PubMed
      16. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007 Dec 6; 357(23):2371-9.
        View in: PubMed
      17. Soller RW, Lightwood JM. Comparison of the packaging and labeling of Target ClearRx with conventional prescription drug packaging and labeling. J Am Pharm Assoc (2003). 2007 Jul-Aug; 47(4):484-90.
        View in: PubMed
      18. Hall SM, Lightwood JM, Humfleet GL, Bostrom A, Reus VI, Muñoz R. Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. J Behav Health Serv Res. 2005 Oct-Dec; 32(4):381-92.
        View in: PubMed
      19. Lightwood J. The economics of smoking and cardiovascular disease. Prog Cardiovasc Dis. 2003 Jul-Aug; 46(1):39-78.
        View in: PubMed
      20. Lightwood J, Fleischmann KE, Glantz SA. Smoking cessation in heart failure: it is never too late. J Am Coll Cardiol. 2001 May; 37(6):1683-4.
        View in: PubMed
      21. Wilson LS, Lightwood J. Model of estimated rates of colorectal cancer from polyp growth by year of surveillance. J Med Screen. 2001; 8(4):187-96.
        View in: PubMed
      22. Lightwood JM, Phibbs CS, Glantz SA. Short-term health and economic benefits of smoking cessation: low birth weight. Pediatrics. 1999 Dec; 104(6):1312-20.
        View in: PubMed
      23. Wilson LS, Lightwood JM. Pancreatic cancer: total costs and utilization of health services. J Surg Oncol. 1999 Jul; 71(3):171-81.
        View in: PubMed
      24. Lightwood JM, Glantz SA. Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke. Circulation. 1997 Aug 19; 96(4):1089-96.
        View in: PubMed
      25. Glantz SA, Fox BJ, Lightwood JM. Tobacco litigation. Issues for public health and public policy. JAMA. 1997 Mar 5; 277(9):751-3.
        View in: PubMed
      Back to TOP